{{ subpage.title }}

Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?

Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Does the arrival of Moderna’s vaccine mean we’re back to normal?

"I think we're going to live with the pandemic for much of 2021, but I don't think it's a binary thing where we have a pandemic and everything's awful, or the pandemic's gone and everything is great again." Noubar Afeyan, co-founder of the COVID-19 vaccine manufacturer Moderna, levels with Ian Bremmer that even with a vaccine the pandemic will not be gone in a matter of day, weeks, or even months. But that doesn't mean that everything will be as bleak as it may feel now. Their conversation was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

What are the “known unknowns” about Moderna’s vaccine?

Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Moderna’s co-founder Noubar Afeyan on the growing pushback against a COVID-19 vaccine

"In any debate, if one side has to offer facts and the other side can offer doubts and they're considered of equal value, then the ones who offer doubts will always have an advantage." Moderna co-founder Noubar Afeyan isn't naïve about the pushback that his company's COVID-19 vaccine will receive when it hits the US market. Disinformation around vaccine safety and efficacy was rampant even before the pandemic began. His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna’s Co-Founder on the COVID-19 Vaccine

A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine

The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan

Listen: The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.

How the Moderna vaccine works, why it’s effective, and how it’ll be distributed

"What we're trying to do is to educate the immune system to see the protein before it's seen the virus." In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10-months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains.

His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

Subscribe to GZERO Media's newsletter, Signal

Latest